Cargando…
Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer
BACKGROUND: Accurate identification of pelvic lymph node metastasis (PLNM) in patients with prostate cancer (PCa) is crucial for determining appropriate treatment options. Here, we built a PLNM-Risk calculator to obtain a precisely informed decision about whether to perform extended pelvic lymph nod...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167242/ https://www.ncbi.nlm.nih.gov/pubmed/34049247 http://dx.doi.org/10.1016/j.ebiom.2021.103395 |
_version_ | 1783701654382575616 |
---|---|
author | Hou, Ying Bao, Jie Song, Yang Bao, Mei-Ling Jiang, Ke-Wen Zhang, Jing Yang, Guang Hu, Chun-Hong Shi, Hai-Bin Wang, Xi-Ming Zhang, Yu-Dong |
author_facet | Hou, Ying Bao, Jie Song, Yang Bao, Mei-Ling Jiang, Ke-Wen Zhang, Jing Yang, Guang Hu, Chun-Hong Shi, Hai-Bin Wang, Xi-Ming Zhang, Yu-Dong |
author_sort | Hou, Ying |
collection | PubMed |
description | BACKGROUND: Accurate identification of pelvic lymph node metastasis (PLNM) in patients with prostate cancer (PCa) is crucial for determining appropriate treatment options. Here, we built a PLNM-Risk calculator to obtain a precisely informed decision about whether to perform extended pelvic lymph node dissection (ePLND). METHODS: The PLNM-Risk calculator was developed in 280 patients and verified internally in 71 patients and externally in 50 patients by integrating a set of radiologists’ interpretations, clinicopathological factors and newly refined imaging indicators from MR images with radiomics machine learning and deep transfer learning algorithms. Its clinical applicability was compared with Briganti and Memorial Sloan Kettering Cancer Center (MSKCC) nomograms. FINDINGS: The PLNM-Risk achieved good diagnostic discrimination with areas under the receiver operating characteristic curve (AUCs) of 0.93 (95% CI, 0.90-0.96), 0.92 (95% CI, 0.84-0.97) and 0.76 (95% CI, 0.62-0.87) in the training/validation, internal test and external test cohorts, respectively. If the number of ePLNDs missed was controlled at < 2%, PLNM-Risk provided both a higher number of ePLNDs spared (PLNM-Risk 59.6% vs MSKCC 44.9% vs Briganti 38.9%) and a lower number of false positives (PLNM-Risk 59.3% vs MSKCC 70.1% and Briganti 72.7%). In follow-up, patients stratified by the PLNM-Risk calculator showed significantly different biochemical recurrence rates after surgery. INTERPRETATION: The PLNM-Risk calculator offers a noninvasive clinical biomarker to predict PLNM for patients with PCa. It shows improved accuracy of diagnosis support and reduced overtreatment burdens for patients with findings suggestive of PCa. FUNDING: This work was supported by the Key Research and Development Program of Jiangsu Province (BE2017756) and the Suzhou Science and Technology Bureau-Science and Technology Demonstration Project (SS201808). |
format | Online Article Text |
id | pubmed-8167242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81672422021-06-05 Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer Hou, Ying Bao, Jie Song, Yang Bao, Mei-Ling Jiang, Ke-Wen Zhang, Jing Yang, Guang Hu, Chun-Hong Shi, Hai-Bin Wang, Xi-Ming Zhang, Yu-Dong EBioMedicine Research Paper BACKGROUND: Accurate identification of pelvic lymph node metastasis (PLNM) in patients with prostate cancer (PCa) is crucial for determining appropriate treatment options. Here, we built a PLNM-Risk calculator to obtain a precisely informed decision about whether to perform extended pelvic lymph node dissection (ePLND). METHODS: The PLNM-Risk calculator was developed in 280 patients and verified internally in 71 patients and externally in 50 patients by integrating a set of radiologists’ interpretations, clinicopathological factors and newly refined imaging indicators from MR images with radiomics machine learning and deep transfer learning algorithms. Its clinical applicability was compared with Briganti and Memorial Sloan Kettering Cancer Center (MSKCC) nomograms. FINDINGS: The PLNM-Risk achieved good diagnostic discrimination with areas under the receiver operating characteristic curve (AUCs) of 0.93 (95% CI, 0.90-0.96), 0.92 (95% CI, 0.84-0.97) and 0.76 (95% CI, 0.62-0.87) in the training/validation, internal test and external test cohorts, respectively. If the number of ePLNDs missed was controlled at < 2%, PLNM-Risk provided both a higher number of ePLNDs spared (PLNM-Risk 59.6% vs MSKCC 44.9% vs Briganti 38.9%) and a lower number of false positives (PLNM-Risk 59.3% vs MSKCC 70.1% and Briganti 72.7%). In follow-up, patients stratified by the PLNM-Risk calculator showed significantly different biochemical recurrence rates after surgery. INTERPRETATION: The PLNM-Risk calculator offers a noninvasive clinical biomarker to predict PLNM for patients with PCa. It shows improved accuracy of diagnosis support and reduced overtreatment burdens for patients with findings suggestive of PCa. FUNDING: This work was supported by the Key Research and Development Program of Jiangsu Province (BE2017756) and the Suzhou Science and Technology Bureau-Science and Technology Demonstration Project (SS201808). Elsevier 2021-05-25 /pmc/articles/PMC8167242/ /pubmed/34049247 http://dx.doi.org/10.1016/j.ebiom.2021.103395 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Hou, Ying Bao, Jie Song, Yang Bao, Mei-Ling Jiang, Ke-Wen Zhang, Jing Yang, Guang Hu, Chun-Hong Shi, Hai-Bin Wang, Xi-Ming Zhang, Yu-Dong Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer |
title | Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer |
title_full | Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer |
title_fullStr | Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer |
title_full_unstemmed | Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer |
title_short | Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer |
title_sort | integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167242/ https://www.ncbi.nlm.nih.gov/pubmed/34049247 http://dx.doi.org/10.1016/j.ebiom.2021.103395 |
work_keys_str_mv | AT houying integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT baojie integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT songyang integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT baomeiling integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT jiangkewen integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT zhangjing integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT yangguang integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT huchunhong integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT shihaibin integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT wangximing integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer AT zhangyudong integrationofclinicopathologicidentificationanddeeptransferrableimagefeaturerepresentationimprovespredictionsoflymphnodemetastasisinprostatecancer |